|4May 24, 6:09 PM ET

Arnold Susan Elizabeth 4

4 · PhaseBio Pharmaceuticals Inc · Filed May 24, 2021

Insider Transaction Report

Form 4
Period: 2021-05-20
Arnold Susan Elizabeth
VP, Preclinical and Chem.
Transactions
  • Award

    Common Stock

    2021-05-20$2.80/sh+5,257$14,72023,241 total
Footnotes (1)
  • [F1]These shares were acquired under the PhaseBio Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Documents

1 file
  • 4
    wf-form4_162189417197411.xmlPrimary

    FORM 4